BDRX Stock Analysis: Buy, Sell, or Hold?
BDRX - Biodexa Pharmaceuticals plc American Depositary Shs
$0.62
-0.01 (-2.01%)
▼
5d:
-8.3%
30d:
-21.02%
90d:
-78.4%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Jun 26, 2026
0d
Get Alerted When BDRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BDRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BDRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BDRX is currently trading at $0.62, which is considered oversold relative to its 30-day fair value range of $0.63 to $1.02.
Technical Outlook: Technically, BDRX is in a strong downtrend. Immediate support is located at $0.57, while resistance sits at $0.74.
Market Sentiment: BDRX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.89 (+1333.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BDRX is in a strong downtrend. Immediate support is located at $0.57, while resistance sits at $0.74.
Market Sentiment: BDRX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.89 (+1333.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.63 -
$1.02
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1333.4% below Wall St target ($8.89)
- CAUTION: Bottoming setup, but lagging the sector by 36% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-8.3%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.63 -
$1.02
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.57
Resistance Level
$0.74
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Wall Street Target
$8.89
(+1333.4%)
Revenue Growth (YoY)
-64.1%
Share & Embed Analysis
Last updated: October 03, 2026 4:49 AM ET
Data refreshes hourly during market hours. Next update: 5:49 AM
Data refreshes hourly during market hours. Next update: 5:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$199 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 63 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$21 | 50 HOLD |
